- Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication, administered intravenously.
- Astemizole: Fosaprepitant may increase the serum concentration of Astemizole. The active metabolite aprepitant is likely responsible for this effect.
- 3. Structure Descriptors of Fosaprepitant. ... Fosaprepitant (CAS NO.172673-20-0) is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant.
- Fosaprepitant is a water soluble, phosphorylated analog of Aprepitant and it is rapidly converted to Aprepitant after intravenous administration.
- Physician reviewed fosaprepitant patient information - includes fosaprepitant description, dosage and directions. - English.
- Ancak her ilaç gibi, fosaprepitantin de yan etkileri ve potansiyel ilaç etkileşimleri olabilir. Bu nedenle, fosaprepitant kullanmadan önce bir doktora danışmak önemlidir.
- Fosaprepitant nedir? Fosaprepitant mide bulantısı ve kusma tetikleyen vücuttaki kimyasalların faaliyetlerini engeller.
- Fosaprepitant ( Emend for Injection (US), Ivemend (EU)) intravenöz olarak uygulanan antiemetik bir ilaçtır . Bu bir ön ilacı bir aprepitant .
- Fosaprepitant is used together with other medications to prevent nausea and vomiting that may be caused by chemotherapy.
- Fosaprepitant belongs to the drug class of NK1 receptor antagonists. Fosaprepitant is used to block the NK1 receptor in the brain that triggers the desire to vomit.